As part of the government's £5.9 ($9.3)-billion science and innovation strategy for 2015–2021, the UK is launching a 'Precision Medicine Catapult' in 2015. The state-funded plan pledges to create a National Formulation Centre to support emerging local companies to produce medicines and chemicals that are deemed high risk or technically challenging. The UK already has seven catapults, including one dedicated to cell therapies (Nat. Biotechnol. 32, 736–741, 2014).